Search results (54)
« Back to NewsChanges in blood cell production over the human lifetime may hold clues to patterns of disease
16 September 2021
Department General MRC MHU MRC WIMM NDCLS OCH Publication Research
A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.
New funding for early diagnosis research using platelets
30 March 2021
Department General MRC MHU MRC WIMM NDCLS OCH Publication Research
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
New RDM Associate Professors and University Research Lecturers
10 July 2020
CVM Department General MRC MHU MRC WIMM NDCLS
Many congratulations to our researchers.
Lunter group joins the MRC WIMM
28 March 2019
Department General MRC WIMM NDCLS
We are pleased to welcome Professor Gerton Lunter and his research group, who will be joining the MRC WIMM Centre for Computational Biology.
2018 RDM graduate prize winners
3 December 2018
CVM Department General MRC WIMM NDCLS
Congratulations to Christopher Booth, Evangelos Oikonomou and Marieke Oudelaar, who are the winners of the 2018 RDM Graduate Prize.
New grant to study pre-cancerous blood disease
28 August 2018
Dr Anna Rose at the MRC Molecular Haematology Unit will study disease pathogenesis and prognosis in a subset of patients with Myelodysplastic Syndromes.
Congratulations to our new Professors
7 August 2018
Athena SWAN Department General IMD MRC MHU MRC WIMM NDCLS OCDEM OCH
Congratulations to Professor Leanne Hodson (Professor of Metabolic Physiology), Professor Adam Mead (Professor of Haematology) Professor Gary Ford (Professor of Stroke Medicine) and Professor Damian Tyler (Professor of Physiological Metabolism) who were all awarded the title of full professor in the recent Recognition of Distinction.
Gene Therapy for Cystic Fibrosis
6 August 2018
Department General NDCLS Research
Professors Deborah Gill and Stephen Hyde, together with their UK Cystic Fibrosis Gene Therapy Consortium partners, have teamed up with Boehringer Ingelheim and Oxford Biomedica to develop gene therapy for cystic fibrosis.